Sapacitabine
Sapacitabine
Sapacitabine (pronounced sah-pah-sit-ah-been) is an orally administered nucleoside analogue used in the treatment of cancer.
Etymology
The term "Sapacitabine" is derived from the Latin word 'sapere' meaning 'to taste' and 'citabine' from the class of drugs it belongs to, the cytarabine.
Usage
Sapacitabine is primarily used in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). It works by inhibiting the growth of cancer cells, thereby slowing or stopping the spread of cancer in the body.
Related Terms
Side Effects
Like all medications, Sapacitabine can cause side effects. Common side effects include nausea, vomiting, diarrhea, and fatigue. More serious side effects can include neutropenia, thrombocytopenia, and anemia.
Precautions
Before starting treatment with Sapacitabine, patients should inform their healthcare provider about any other medications they are taking, as well as any known allergies to medications.
External links
- Medical encyclopedia article on Sapacitabine
- Wikipedia's article - Sapacitabine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski